跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorios Cinfa S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 16, 2020
Approval ID
4271248d3d24db59
Company
Laboratorios Cinfa S.A.
Type
Standard
Approval Details
Approval Id
4271248d3d24db59
Drug Cima Aemps Name
AMLODIPINO/VALSARTAN/HIDROCLOROTIAZIDA CINFA 5 MG/160 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
85179
Holder Company Name
Laboratorios Cinfa S.A.
Marketing Company Name
Laboratorios Cinfa S.A.
Authorization Date
2020-06-16
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg/160 mg/ 25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Laboratorios Cinfa S.A.
Active Ingredients
AMLODIPINO BESILATO
6,94 mg
VALSARTAN
160 mg
HIDROCLOROTIAZIDA
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 16, 2020
Approval ID
4271248d3d24db59
Type
Standard
Back to CIMA-AEMPS Approvals